Related to this topic: Equipment | Books | Your Experience | Other resources | Glossaries
Print options:
Other options:
(what's this?)
PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.
Myoglobinuria
Myoglobin is found in muscles and its main function is to carry oxygen to muscle cells. It has similarities to haemoglobin, in that it is a protein chain containing haem, however it is structurally different.1
Myoglobinuria is the presence of myoglobin in the urine and usually represents muscle damage.
Once muscles are damaged e.g. trauma, myoglobin is released in the circulation. There are usually very low levels of myoglobin in the urine. Once myoglobin is released from muscles it is taken up by haptoglobins - a process that becomes rapidly saturated. Any free myoglobin then enters renal tubules to be excreted; however it may precipitate leading to obstruction and subsequent acute renal failure.1
Myoglobinuria can cause a positive urine dipstick for blood, thus being confused with haematuria. Myoglobin in the urine usually darkens the urine.
The next step is to obtain urine microscopy specifically looking for myoglobinuria.
There are also direct tests for myoglobinuria such as immunoassays.
Any cause of muscle breakdown, for example:
Trauma
|
Patients with myoglobinuria alone may have very few problems, however if myoglobinuria is severe they can develop complications. Sometimes the words myoglobinuria and rhabdomyolysis are used interchangeably.
Definition
Rhabdomyolysis can be defined as a syndrome associated with breakdown of skeletal muscle fibres leading to release of muscle contents into the circulation resulting in multiple complications including hyperkalaemia and cardiac arrest.
Epidemiology
The exact incidence of rhabdomyolysis varies with the underlying cause.1 Rhabdomyolysis accounts for 7% of all cases of acute renal failure.
Aetiology
Causes are similar as for myoglobinuria - the commonest causes being
| Alcohol abuse Overexertion Trauma, burns and compartment syndromes Drugs e.g. statins, erythromycin, corticosteroids, ecstasy,3 heroin, cocaine and amphetamines Heat stroke Neuroleptic malignant syndrome Infections, such as, influenza virus, EBV, streptococcus and legionella. Snake bites Hypo and hyperthyroidism Diabetic Ketoacidosis Genetic causes e.g. abnormalities of lipid metabolism (e.g. carnitine deficiency) or abnormalities of carbohydrate metabolism (e.g. phosphofructokinase deficiency). |
The injured muscle results in calcium moving into cells which causes the cells to die leading to muscle necrosis and leakage of ions and proteins into the circulation.4
The substances released are
- Potassium
- Phosphate
- Myoglobin
- Creatine kinase
- Urate
Presentation
- Many features are non-specific and therefore a high index of clinical suspicion is required.
- There may be features relating to the underlying cause e.g. swollen, painful, paraesthesia of limbs in compartment syndrome or muscle tenderness.
- Fever and malaise may be present.
- Elderly may present with confusion, agitation and delirium.
- Patients may be anuric.
- Tea coloured urine may be present.
Diagnosis
- Based on clinical grounds e.g. supportive case history.
- Urine - tea coloured and positive for blood on dipstick testing.
- Urine microscopy - this can detect myoglobin and will note presence or lack of red blood cells.
- Creatine kinase - will be raised, may be up to several 10,000's.
- Electrolytes - high potassium, low calcium, high phosphate.
- Investigations to delineate the underlying cause may be indicated e.g. muscle biopsy.
Complications
The complications of rhabdomyolysis are the cause of mortality and morbidity in these patients.
These include
- Hyperkalaemia causing arrhythmias and cardiac arrest.
- Hypocalcaemia (worsened by hyperphosphataemia).
- Hepatic abnormalities - but AST may be high representing muscle AST.
- Metabolic acidosis.
- Acute renal failure from precipitation and obstruction of renal tubules by myoglobinuria and hypovolaemia.
- Disseminated intravascular coagulation.
- Pooling of fluid in the damaged muscle which adds to hypovolaemia and can lead to a compartment syndrome.
There may also be complications resulting from the original insult e.g. burns associated with sepsis.
Treatment
- Fluid rehydration - needs to be prompt.
- Treat hyperkalaemia -calcium gluconate (if indicated) and dextrose-insulin infusions.
- Diuretics - mannitol has been used but its use is contentious. Other diuretics have not been shown to improve renal impairment. Diuretics should not be used until hypovolaemia is corrected.4
- Alkaline diuresis - alkalinisation of the urine with bicarbonate can reduce the risk of acute renal failure - however, there is no clear evidence as to its benefit or whether it is any better then simple aggressive hydration with intravenous fluids.4
- If renal function fails to improve patients are at risk of acute tubular necrosis in which case haemodialysis may be necessary.5
- Hypocalcaemia and hyperphosphataemia need not be corrected unless dangerously low - they improve as CK falls.
Statins are widely used and their use has been associated with a reduction in mortality and morbidity in ischaemic heart disease and cerebrovascular disease.
They are associated with muscle aches and pains and can cause myositis and rhabdomyolysis which can be fatal.6
Cerivistatin was the most frequently used statin with associated rhabdomyolysis and was subsequently withdrawn.7,8
The risk of rhabdomyolysis with statins is increased in the elderly, with use of interacting medications (e.g. fibrates) and hypothyroidism.
If patients on statins develop myositis (muscle pain, muscle tenderness and weakness) or myalgia then the statin should be stopped and CK checked urgently. If CK level is normal consider changing to another member or restart at a lower dose with cautious monitoring. Presence of rhabdomyolysis will require termination of treatment and management as described above.
Document References
- Beetham R; Biochemical investigation of suspected rhabdomyolysis.; Ann Clin Biochem. 2000 Sep;37 ( Pt 5):581-7.
- Carroll RR, Hall EL, Kitchens CS; Canebrake rattlesnake envenomation.; Ann Emerg Med. 1997 Jul;30(1):45-8. [abstract]
- Liechti ME, Kunz I, Kupferschmidt H; Acute medical problems due to Ecstasy use. Case-series of emergency department visits.; Swiss Med Wkly. 2005 Oct 29;135(43-44):652-7. [abstract]
- Sauret JM, Marinides G, Wang GK; Rhabdomyolysis.; Am Fam Physician. 2002 Mar 1;65(5):907-12. [abstract]
- Sulowicz W, Walatek B, Sydor A, et al; Acute renal failure in patients with rhabdomyolysis.; Med Sci Monit. 2002 Jan;8(1):CR24-7. [abstract]
- Evans M, Rees A; The myotoxicity of statins.; Curr Opin Lipidol. 2002 Aug;13(4):415-20. [abstract]
- Thompson PD, Clarkson P, Karas RH; Statin-associated myopathy.; JAMA. 2003 Apr 2;289(13):1681-90. [abstract]
- Hendriks F, Kooman JP, van der Sande FM; Massive rhabdomyolysis and life threatening hyperkalaemia in a patient with the combination of cerivastatin and gemfibrozil.; Nephrol Dial Transplant. 2001 Dec;16(12):2418-9.
DocID: 1111
Document Version: 20
DocRef: bgp674
Last Updated: 21 Aug 2006
Review Date: 20 Aug 2008
Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.
Related pages in Patient UK
Your Experience (^ top of page)
Please add your experience about this condition / medicineOther - Useful resources (^ top of page)
Pictures, diagrams, photos, images, etc.Evidence based medicine
Online textbooks and journals
A-Z of UK Guidelines
A-Z of Online Videos
Medline
Other good health sites
Medical equipment products related to this topic (^ top of page)

Books related to this topic (^ top of page)

Want to search some more? Use the Google Search box below to search our site.

Would you like to try our advanced on-line knowledge support system designed to provide professionals with relevant up to date information about recognition and management of disease or take the Mentor Challenge?
Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.
